Nael Alakel, MD

Dr
Department of Internal Medicine I, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany, Germany

Disclosure(s): Amgen: personal fee, travel grant; Gilead: personal fee, travel grant; MSD Sharp and Dohme GmbH: personal fee, travel grant; Pfizer: personal fee, travel grant

Poster(s):

• 1142 - Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET